References
Bishop KI, Curran HV (1995) Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil. Psychopharmacology 121:267–278
Braestrup C, Honore T, Nielsen M, Petersen EN, Jensen LH (1984) Ligands for benzodiazepine receptors with positive and negative efficacy. Biochem Pharmacol 33:859–862
Burt DR, Kamatchi GL (1991) GABAA receptor subtypes: from pharmacology to molecular biology. FASEB J 5:2916–2923
Curran HV, Birch B (1991) Differentiating the sedative, psychomotor and mnesic effects of benzodiazepines: a study with midazolam and the benzodiazepine antagonist, flumazenil. Psychopharmacology 103:519–523
Dawson GR, Crawford SP, Collinson N, Iversen SD, Tricklebank MD (1995) Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology 118:316–323
De Vry J, Slangen JL (1985a) The Ro15-1788 cue: evidence for benzodiazepine agonist and inverse agonist properties. Eur J Pharmacol 119:193–197
De Vry J, Slangen JL (1985b) Stimulus control induced by the benzodiazepine antagonist Ro15-1788 in the rat. Psychopharmacology 85:483–485
Gardner CR, Tully WR, Hedgecock CJR (1993) The rapidly expanding range of neuronal benzodiazepine receptor ligands. Prog Neurobiol 40:1–61
Haefely W (1988) The preclinical pharmacology of flumazenil. Eur J Anaesthesiol 2:25–36
Higgitt A, Lader M, Fonagy P (1986) The effects of the benzodiazepine antagonist Ro15-1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology 89:395–403
Hommer D, Weingartner H, Breier A (1993) Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment. Psychopharmacology 112:455–460
Im HK, Im WB, Carter DB, McKinley DD (1995) Interaction of β-carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors. Br J Pharmacol 114:1040–1044
Kapczinski F, Curran V, Gray J, Lader M (1994) Flumazenil has an anxiolytic effect in stimulated stress. Psychopharmacology 114:187–189
Kapczinski F, Sherman D, Williams R, Lader M, Curran V (1995) Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients. Psychopharmacology 120:220–226
Lal H, Forster MJ (1990) Flumazenil improves active avoidance performance in aging NZB/B1NJ and C57BL/6NNia mice. Pharmacol Biochem Behav 35:747–750
Lal H, Kumar B, Forster MJ (1988) Enhancement of learning and memory in mice by a benzodiazepine antagonist. FASEB J 2:2707–2711
Lee C, Rodgers RJ (1991) Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice. Neuropharmacology 30:1263–1267
Lüddens H, Korpi ER, Seeburg PH (1995) GABAA/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 34:245–254
Macdonald RL, Olsen RW (1994) GABAA receptor channels. Annu Rev Neurosci 17:569–602
Marczynksi TJ, Artwohl J, Marczynska B (1994) Chronic administration of flumazenil increases life span and protects rats from age-related loss of cognitive functions: a benzodiazepine/GABAergic hypothesis of brain aging. Neurobiol Aging 15:69–84
McKernan RM, Whiting PJ (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurol Sci 19:139–143
Miller JA (1994) Evidence for a modified model of agonist and inverse agonist actions at the GABAA receptor. In: Sarter M, Nutt D, Lister R (eds) Benzodiazepine receptor inverse agonists. Wiley-Liss, New York, pp 25–40
Miller JA, Dudley MW, Kehne JH, Sorensen SM, Kane JM (1992) MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties. Br J Psychopharmacol 107:78–86
Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Arch Gen Psychiatry 47:917–925
Puia G, Vicini S, Seeburg PH, Costa E (1991) Influence of recombinant γ-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of γ-aminobutyric acid-gated Cl− current. Mol Pharmacol 39:691–696
Rowan GA, Lucki I (1992) Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil. Psychopharmacology 107:103–112
Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioural pharmacology of benzodiazepine (ω) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355–372
Santucci V, Fournier M, Worms P, Keane P, Biziere K (1989) Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 340:93–100
Sarter M, Nutt DJ (1994) Inverse agonists as therapeutic drugs. In: Sarter M, Nutt D, Lister R (eds) Benzodiazepine receptor inverse agonists. Wiley-Liss, New York, pp 271–280
Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, Seeburg PA, Barnard EA (1987) Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family. Nature 328:221–227
Seifritz E, Hemmeter U, Trachsel L, Lauer CJ, Hatzinger M, Emrich HM, Holsboer F, Holsboer-Trachsler E (1995) Effects of flumazenil on recovery sleep and hormonal secretion after sleep deprivation in male controls. Psychopharmacology 120:449–456
Steiger A, Guldner J, Lauer CJ, Meschenmoser C, Pollmächter T, Holsboer F (1994) Flumazenil exerts intrinsic activity on sleep EEG and nocturnal hormone secretion in normal controls. Psychopharmacology 113:334–338
Stephens DN (ed) (1993) Anxiolytic β-carbolines. Springer, Berlin
Stephens DN, Voet B (1994) Differential effects of anxiolytic and non-anxiolytic benzodiazepine receptor ligands on performance of a differential reinforcement of low rate (DRL) schedule. Behav Pharmacol 5:4–14
Urbancic M, Gadek MA, Marczynski TJ (1990) Chronic exposure of flumazenil: anxiolytic effect and increase exploratory behavior. Pharmacol Biochem Behav 35:503–509
Vivian JA, Farrell WJ, Sapperstein SB, Miczek KA (1994) Diazepam withdrawal: effects of diazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalizations. Psychopharmacology 114:101–108
Weerts EM, Tornatzky W, Miczek KA (1993) “Anxiolytic” and “anxiogenic” benzodiazepines and β-carbolines: effects on aggressive and social behavior in rats and squirrel monkeys. Psychopharmacology 110:451–459
Yeh HH, Grigorenko EV (1995) Deciphering the native GABAA receptor: is there hope? J Neurosci Res 41:567–571
Zhao TJ, Chiu TH, Rosenberg HC (1994) Reduced expression of γ-aminobutyric acid type A/benzodiazepine receptor γ2 and α5 subunit mRNA in brain regions of flurazepam-treated rats. Mol Pharmacol 45:657–663
Zhu WJ, Vicini S, Harris BT, Grayson DR (1995) NMDA-mediated modulation of γ-aminobutyric acid type A receptor function in cerebellar granule neurons. J Neurosci 15:7692–7701
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarter, M., Berntson, G.G., Bruno, J.P. et al. Agonizing over antagonizing: what do benzodiazepine receptor antagonists demonstrate?. Psychopharmacology 126, 182–184 (1996). https://doi.org/10.1007/BF02246355
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246355